ATS Urges Do-Over on House of Representatives FY25 Interior & Environment Appropriations Bill

American Thoracic Society Environmental Health Policy Committee Chair Alison Lee, MD, strongly opposes proposed FY25 cuts that would jeopardize the health of all Americans: “Clean air, clean water and a healthy environment are essential to the health of all Americans. That is why I am calling on Congress to scrap the current FY25 Interior and Environment Appropriations bill and start over.

Statement on Passage of Legislation Expanding Access to Breast Cancer Treatment for Missourians

Susan G. Komen®, the world’s leading breast cancer organization, today issued the following statement on the passage of legislation to expand eligibility for the MO HealthNet Breast and Cervical Cancer Treatment (BCCT) program, ensuring that all eligible individuals have access to vital treatment services, regardless of where they received their cancer screening and diagnosis.

AACN Looks to the Senate as House Proposes Cuts and Consolidation of Programs Supporting Nursing Education and Research

The House Appropriations Committee advanced their Fiscal Year (FY) 2025 Labor, Health and Human Services, and Education (LHHS-ED) spending bill by a vote of 31 to 25. This bill proposes steep cuts and consolidation of programs throughout the Departments of Health and Human Services (HHS) and Education.

The Association for Diagnostics & Laboratory Medicine (formerly AACC) supports Rep. Cassidy’s letter asking the FDA to explain how it plans to abide by the recent Supreme Court decision curtailing the power of federal agencies

On June 28, in Loper Bright Enterprises v. Raimondo, the Supreme Court overturned the so-called Chevron doctrine and reinforced that Congress and the courts are responsible for writing and interpreting laws, respectively, not federal agencies.

Association for Diagnostics & Laboratory Medicine (formerly AACC) survey finds that FDA’s final laboratory developed tests rule will impede the fight against the U.S.’s drug epidemic

Today, the Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) released the results of a survey that ADLM conducted to determine how the Food and Drug Administration’s (FDA’s) final laboratory developed tests rule will impact patient access to essential tests. The survey found that, in spite of certain tests being exempt from the rule, it will still force many laboratories, particularly those in hospitals, to discontinue critical tests, including those needed to identify prescription and illegal drug use.

ASTRO applauds new bipartisan legislation to reform prior authorization for Medicare Advantage patients

The American Society for Radiation Oncology (ASTRO) applauded today’s introduction of bipartisan federal legislation to address critical flaws in the prior authorization process. “The prior authorization system in its current form is ineffective and harmful to patients, creating unnecessary delays to lifesaving cancer treatments and distress for the people who need them,” said Jeff M. Michalski, MD, MBA, FASTRO, Chair of the ASTRO Board of Directors.

Endocrine Society urges passage of the Right to IVF Act

The Endocrine Society endorses the Right to IVF Act, which was introduced by Senators Cory Booker (D-NJ), Patty Murray (D-WA) and Tammy Duckworth (D-IL) to protect and expand nationwide access to fertility treatment, including in vitro fertilization (IVF), and urges the Senate to pass the Right to IVF Act on June 12th to ensure that the freedom to start and grow a family is protected and accessible to everyone in the United States.

AANA Issues Updated Practice Considerations for Ketamine Therapy for Psychiatric Disorders and Chronic Pain Management

The American Association of Nurse Anesthesiology (AANA) recently updated its practice considerations addressing ketamine therapy to cite the most current studies, as AANA continues to support a patient-centered, interdisciplinary approach to providing care and treatment to persons with psychiatric disorders or chronic pain.

INCREASING ORGAN TRANSPLANT ACCESS (IOTA) MODEL ANNOUNCED TO INCREASE PATIENT ACCESS TO KIDNEY TRANSPLANTATION

The long-awaited Increasing Organ Transplant Access (IOTA) Model was released yesterday by the Center for Medicare and Medicaid Innovation (CMMI) focusing on increasing patients’ access to kidney transplantation across the United States.

The Association for Diagnostics & Laboratory Medicine (formerly AACC) opposes FDA ruling on laboratory developed tests; urges FDA to involve all stakeholders in modernization of laboratory developed test regulation in order to improve patient care

We at the Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) strongly disagree with the Food and Drug Administration’s (FDA’s) decision to issue a final rule placing laboratory developed tests under duplicative FDA authority, in addition to these tests’ current regulation under the Centers for Medicare & Medicaid Services (CMS).

AMERICAN SOCIETY OF NEPHROLOGY CALLS ON CONGRESS TO INCREASE FUNDING FOR THE US TRANSPLANT SYSTEM

Today, leaders from the American Society of Nephrology (ASN) will meet with their congressional delegations and call for their support of an $8 million increase for the Health Resources and Services Administration (HRSA) Organ Transplantation Program in FY 25 This funding, totaling $67 million, will be used to continue Congress’ commitment to people seeking a transplant and will implement reforms to modernize the transplant system and make transplant care more accessible.

International Consensus Statement Published in Nature Reviews Nephrology Calls for Urgent Action to Address Chronic Kidney Disease on the Global Public Health Agenda

Nature Reviews Nephrology published a landmark international consensus statement titled “Chronic Kidney Disease and the Global Public Health Agenda: An International Consensus.” Authored by a coalition of leading experts, stakeholders, and nephrology societies, the publication highlights critical policy, advocacy, and implementation needs to alleviate the growing burden of kidney disease worldwide.

American Society of Nephrology Celebrates Transformational Transplant Funding

Delivering on its commitment to increase Americans’ access to kidney transplant by improving the transparency and efficiency of our nation’s transplant network, Congress this week approved a much-needed $23 million federal funding increase in fiscal year (FY) 2024 for the Health Resources and Services Administration (HRSA), the agency responsible for overseeing the Organ Procurement and Transplantation Network (OPTN).

US House Foreign Affairs Committee Advances Bipartisan Bill for Global Conservation

“USFICA would create a public-private partnership to save wildlife and wild places around the world. What that means is government funds would leverage private support, making public dollars go much farther. And those monies would go directly to protected areas and parks around the world.” John Calvelli, WCS Executive VP for Public Affairs

Association for Diagnostics & Laboratory Medicine (formerly AACC) Submits Testimony to Congress Opposing FDA’s Proposed LDTs Rule

“Today, we at the Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) provided testimony to Congress regarding the impact of the Food and Drug Administration’s (FDA’s) proposed rule to impose FDA oversight on laboratory developed tests in addition to Centers for Medicare & Medicaid Services (CMS) oversight. While we share FDA’s goal of ensuring that laboratory developed tests are safe and effective, we have serious concerns about the agency’s proposal. If finalized, this rule would create a burdensome dual regulatory structure that would limit patient access to many life-saving tests.

AANA Advocates for Excellence During Patient Safety Awareness Week

During Patient Safety Awareness Week, March 10-16, 2024, the American Association of Nurse Anesthesiology (AANA) proudly joins the Institute for Healthcare Improvement in raising awareness and promote initiatives that make healthcare safer for patients and the healthcare workforce.

Alabama Gov. Kay Ivey signed a bill into law aimed at protecting in vitro fertilization patients and providers from legal liability with some clinics poised to lift a hold on certain IVF services as early as this week.

Sonia Suter is a professor of law at the George Washington University Law School and founding director of the Health Law Initiative. She is an expert on issues at the intersection of law, medicine, and bioethics, with a particular focus…

American Society of Anesthesiologists Extremely Frustrated with Another Year of Medicare Payment Cuts

Today the American Society of Anesthesiologists (ASA) expressed disappointment with the congressional “doc fix” provisions included in the recently passed government funding package. Instead of blocking the fourth straight year of Medicare payment cuts to physicians, the provisions only reduce the size of the 2024 payment cut by about half, leaving physician practices with unsustainable payment cuts.

AMERICAN SOCIETY OF NEPHROLOGY APPLAUDS THE WAYS AND MEANS COMMITTEE FOR ADVANCING THE KIDNEY PATIENT ACT (HR 5074)

The American Society of Nephrology (ASN) commends congressional leaders on the House Ways and Means committee for advancing the Kidney PATIENT Act, bipartisan legislation to maintain patient access to oral-only medications by retaining coverage through Medicare Part D.
More than 500,000 patients undergoing dialysis require numerous medications to manage their health, and, for many patients this includes certain oral-only medications, such as phosphate binders. These vital oral-only medications are best dispensed by pharmacies, who have dedicated infrastructure suited to promoting at-home medication adherence and are more accessible to patients.

AMERICAN SOCIETY OF NEPHROLOGY COMMENDS CONGRESS FOR HIGHLIGHTING THE HONOR OUR LIVING DONORS ACT (H.R. 6020)

At a hearing today focused on supporting patients with rare diseases, the House Energy and Commerce Health Subcommittee will consider Honor Our Living Donors Act (H.R. 6020), legislation to improve support for living organ donors.

AANA Applauds Addition of CRNAs To SAMHSA Practitioner List

In a recent final regulation issued by the Substance Abuse and Mental Health Services Administration (SAMHSA), CRNAs, also known as nurse anesthesiologists or nurse anesthetists, have been permanently added to the definition of a practitioner who is appropriately licensed by a state to prescribe and dispense medications for the treatment of opioid use disorder (OUD).

AACN Applauds the Reintroduction of the Future Advancement of Academic Nursing (FAAN) Act in Congress

AACN applauds the introduction of the Future Advancement of Academic Nursing (FAAN) Act (H.R.7266/S.3770) by our Senate Nursing Caucus Co-Chair, Senator Jeff Merkley (D-OR) and House Nursing Caucus Vice Co-Chair, and nurse Congresswoman Lauren Underwood (D-IL-14). This legislation calls for historic investments to address immediate nursing education needs, while providing proactive measures to meet future workforce demands.

THE AMERICAN SOCIETY OF NEPHROLOGY APPALUDS THE INTRODUCTION OF THE HONOR OUR LIVING DONORS (HOLD) ACT, H.R. 6020

The American Society of Nephrology, representing 21,000 nephrologists, scientists and other kidney care professionals, today voiced its support for the Honor Our Living Donors (HOLD) Act (H.R. 6020), new legislation introduced by U.S. Representatives Jay Obernolte (R-CA-23) and Suzanne DelBene (D-WA-1) to qualify federal support for living organ donors based on donor income as opposed to current requirements that base support on the organ recipient’s income.

AANA Updates, Publishes Analgesia and Anesthesia Practice Considerations for The Substance Use Disorder Patient

To help ensure that patients with active substance use disorder, on medication-assisted treatment, or in abstinent recovery continue to receive high-quality, safe pain management and anesthesia care, the American Association of Nurse Anesthesiology (AANA) has published its updated analgesia and anesthesia practice considerations.

ACP says ‘Enough is enough,’ vows to continue to fight for lower drug prices for patients

ACP leaders have strong words for pharmaceutical and other health care companies that are challenging the implementation of the Medicare prescription drug price negotiation program. So far, these businesses have spent approximately $400 million challenging the program in U.S. courts. ACP, along with other medical societies, is pushing back.

Association for Diagnostics & Laboratory Medicine (formerly AACC) Statement on Proposed FDA Rule on Laboratory Developed Tests

We at the Association for Diagnostics & Laboratory Medicine were disappointed to see the U.S. Food & Drug Administration’s (FDA’s) attempt to circumvent Congress with its new proposed rule to duplicate the regulation of laboratory developed tests by placing these tests under FDA authority, in addition to their current regulation under the Centers for Medicare and Medicaid Services.